Kyle Gregory Mitchell

7PUBLICATIONS
11CO-AUTHORS
Haematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPeripheral nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 24, 2025
Intratumoral neutrophil-to-lymphocyte ratio is mirrored by circulating neutrophil-to-lymphocyte ratio in non-small cell lung cancer.

Kyle G Mitchell, Younghee Lee, Nathaniel Deboever

|Jul 15, 2024
Signet ring cells and conditional survival after trimodality therapy for esophageal adenocarcinoma.

Kyle G Mitchell, Hope Feldman, Denái R Milton

|Feb 03, 2022
Combined IL-2, agonistic CD3 and 4-1BB stimulation preserve clonotype hierarchy in propagated non-small cell lung cancer tumor-infiltrating lymphocytes.

Parin Shah, Marie-Andrée Forget, Meredith L Frank

|Aug 11, 2021
Oncogene-specific differences in tumor mutational burden, PD-L1 expression, and outcomes from immunotherapy in non-small cell lung cancer.

Marcelo V Negrao, Ferdinandos Skoulidis, Meagan Montesion

|May 01, 2020
Neutrophil expansion defines an immunoinhibitory peripheral and intratumoral inflammatory milieu in resected non-small cell lung cancer: a descriptive analysis of a prospectively immunoprofiled cohort.

Kyle G Mitchell, Lixia Diao, Tatiana Karpinets

|Jul 11, 2019
Colorectal cancer mutations are associated with survival and recurrence after pulmonary metastasectomy.

Erin M Corsini, Kyle G Mitchell, Reza J Mehran

Pageof 2

Frequent Collaborators

3 joint publications

Marcelo V Negrao

3 joint publications

Jianjun Zhang

2 joint publications

Alexandre Reuben

1 joint publications

Erin M Corsini